Literature DB >> 23166088

Epilepsy due to 20q13.33 subtelomere deletion masquerading as pyridoxine-dependent epilepsy.

Heather C Mefford1, Joseph Cook, Sidney M Gospe.   

Abstract

A cause of antiepileptic medication resistant seizures presenting in neonates and young infants is pyridoxine-dependent epilepsy (PDE), an organic aciduria, which is due to recessive mutations in the ALDH7A1 gene, resulting in deficiency of antiquitin. Since the discovery of molecular basis of this disorder, a few patients have been reported with a similar clinical phenotype but without evidence of antiqutin dysfunction. We report on a patient who had carried a clinical diagnosis of PDE for 7 years, but who was than shown to have normal ALDH7A1 sequencing and the absence of biomarkers characteristic of this familial epilepsy. Array comparative genomic hybridization (CGH) demonstrated a 1.5-Mb terminal deletion of the long arm of chromosome 20, which included deletion of the KCNQ2 and CHRNA4 genes, both of which have been associated with specific epilepsy syndromes. We suggest that this boy's neonatal epilepsy and neurodevelopmental disabilities are secondary to this deletion and that his clinical response to pyridoxine was coincidental. This patient's history emphasizes the utility of array CGH in the evaluation of children with epilepsy of unknown etiology.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23166088     DOI: 10.1002/ajmg.a.35633

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  7 in total

1.  Improving molecular diagnosis in epilepsy by a dedicated high-throughput sequencing platform.

Authors:  Erika Della Mina; Roberto Ciccone; Francesca Brustia; Baran Bayindir; Ivan Limongelli; Annalisa Vetro; Maria Iascone; Laura Pezzoli; Riccardo Bellazzi; Gianfranco Perotti; Valentina De Giorgis; Simona Lunghi; Giangennaro Coppola; Simona Orcesi; Pietro Merli; Salvatore Savasta; Pierangelo Veggiotti; Orsetta Zuffardi
Journal:  Eur J Hum Genet       Date:  2014-05-21       Impact factor: 4.246

2.  Seizures Due to a KCNQ2 Mutation: Treatment with Vitamin B6.

Authors:  Emma S Reid; Hywel Williams; Polona Le Quesne Stabej; Chela James; Louise Ocaka; Chiara Bacchelli; Emma J Footitt; Stewart Boyd; Maureen A Cleary; Philippa B Mills; Peter T Clayton
Journal:  JIMD Rep       Date:  2015-10-08

3.  Contiguous deletion of KCNQ2 and CHRNA4 may cause a different disorder from benign familial neonatal seizures.

Authors:  Franchette T Pascual; Klaas J Wierenga; Yu-Tze Ng
Journal:  Epilepsy Behav Case Rep       Date:  2013-03-01

4.  KCNQ2-Related Neonatal Epilepsy Treated With Vitamin B6: A Report of Two Cases and Literature Review.

Authors:  Greta Amore; Ambra Butera; Giulia Spoto; Giulia Valentini; Maria Concetta Saia; Vincenzo Salpietro; Francesco Calì; Gabriella Di Rosa; Antonio Gennaro Nicotera
Journal:  Front Neurol       Date:  2022-03-25       Impact factor: 4.003

5.  Clinical Study of 30 Novel KCNQ2 Variants/Deletions in KCNQ2-Related Disorders.

Authors:  Tiantian Xiao; Xiang Chen; Yan Xu; Huiyao Chen; Xinran Dong; Lin Yang; Bingbing Wu; Liping Chen; Long Li; Deyi Zhuang; Dongmei Chen; Yuanfeng Zhou; Huijun Wang; Wenhao Zhou
Journal:  Front Mol Neurosci       Date:  2022-04-26       Impact factor: 5.639

Review 6.  Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.

Authors:  Jun Chen; Qiuji Tao; Lijuan Fan; Yajun Shen; Jinfeng Liu; Huan Luo; Zuozhen Yang; Mengmeng Liang; Jing Gan
Journal:  Mol Genet Genomic Med       Date:  2022-07-30       Impact factor: 2.473

7.  A boy with conduct disorder (CD), attention deficit hyperactivity disorder (ADHD), borderline intellectual disability, and 47,XXY syndrome in combination with a 7q11.23 duplication, 11p15.5 deletion, and 20q13.33 deletion.

Authors:  Gerasimos Kolaitis; Christian G Bouwkamp; Alexia Papakonstantinou; Ioanna Otheiti; Maria Belivanaki; Styliani Haritaki; Terpsihori Korpa; Zinovia Albani; Elena Terzioglou; Polyxeni Apostola; Aggeliki Skamnaki; Athena Xaidara; Konstantina Kosma; Sophia Kitsiou-Tzeli; Maria Tzetis
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2016-09-15       Impact factor: 3.033

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.